[LXRX] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
12-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- 207.95%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 139 298 23,995 322,073 63,209 90,335 83,337 -65.54%
PBT -101,944 -87,758 -58,574 124,119 -120,548 -141,711 -141,429 -5.30%
Tax 1,184 510 11,610 -6,014 3,508 -12,661 4,511 -19.97%
NP -103,128 -88,268 -70,184 130,133 -120,548 -129,050 -141,429 -5.12%
Tax Rate - - - 4.85% - - - -
Total Cost 103,267 88,566 94,179 191,940 183,757 219,385 224,766 -12.15%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -74,192.81 -29,620.13 -292.49 40.40 -190.71 -142.86 -169.71 175.36%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.62 -0.61 -0.63 1.23 -1.14 -1.23 -1.36 -12.26%
EPS Diluted -0.62 -0.61 -0.63 1.11 -1.14 -1.23 -1.36 -12.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.